相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adenosine A2Areceptor antagonists: from caffeine to selective non-xanthines
Kenneth A. Jacobson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Peter Illes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease
Germain Homerin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders
Anindya Bhattacharya et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17
Thanigaimalai Pillaiyar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Ligand binding and activation of UTP-activated G protein-coupled P2Y2 and P2Y4 receptors elucidated by mutagenesis, pharmacological and computational studies
Isaac Y. Attah et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)
Update of P2Y Receptor Pharmacology: IUPHAR Review:27
Kenneth A. Jacobson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists
Maria Joao Matos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A2B adenosine receptor inhibition by the dihydropyridine calcium channel blocker nifedipine involves colonic fluid secretion
Teita Asano et al.
SCIENTIFIC REPORTS (2020)
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease
Jiang-Fan Chen et al.
PURINERGIC SIGNALLING (2020)
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A3 Adenosine Receptors: Affinity Enhancement by N6-(2-Phenylethyl) Substitution
Dilip K. Tosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Chronic Morphine-Induced Changes in Signaling at the A3 Adenosine Receptor Contribute to Morphine-Induced Hyperalgesia, Tolerance, and Withdrawal
Timothy M. Doyle et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction
Mahmoud G. Khalafalla et al.
FRONTIERS IN PHARMACOLOGY (2020)
Treatment of chronic neuropathic pain: purine receptor modulation
Kenneth A. Jacobson et al.
PAIN (2020)
Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke
Pranay Srivastava et al.
EXPERIMENTAL NEUROLOGY (2020)
A 15-Year Study on Up4A in Cardiovascular Disease
Zhichao Zhou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity
Alexandra Borodovsky et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice
Maria Agustina Battistone et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists
Ana Mallo-Abreu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Exploration of Alternative Scaffolds for P2Y14 Receptor Antagonists Containing a Biaryl Core
Young-Hwan Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists Part 2: Discovery of orally bioavailable compounds
Hiroyuki Tobinaga et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
Kenneth A. Jacobson et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study
Alyn H. Morice et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration
Denis Garceau et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)
Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y2 receptor antagonist
Nicole Brockmann et al.
PURINERGIC SIGNALLING (2019)
P2X7 Interactions and Signaling - Making Head or Tail of It
Robin Kopp et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome
Dong-Hyun Kang et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2019)
ATP-Gated P2X Receptor Channels: Molecular Insights into Functional Roles
Ralf Schmid et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets
Tiziana Vaisitti et al.
FRONTIERS IN IMMUNOLOGY (2019)
100 Years of Suramin
Natalie Wiedemar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Antithrombotic P2Y12 receptor antagonists: recent developments in drug-discovery
Younis Baqi et al.
DRUG DISCOVERY TODAY (2019)
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Detlev Boison et al.
CANCER CELL (2019)
Investigation on 2',3'-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists
Diego Dal Ben et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent
Hien Thi Thu Le et al.
SCIENTIFIC REPORTS (2019)
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview
Diego Dal Ben et al.
PHARMACEUTICALS (2019)
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases
Catia Lambertucci et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mapping the binding site of the P2X receptor antagonist PPADS reveals the importance of orthosteric site charge and the cysteine-rich head region
Hong Huo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Druggable negative allosteric site of P2X3 receptors
Jin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The Molecular Determinants of Small-Molecule Ligand Binding at P2X Receptors
Gaia Pasqualetto et al.
FRONTIERS IN PHARMACOLOGY (2018)
ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping
Hongbin Yang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses
Antonella Ciancetta et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor
Muhammad Rafehi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2Receptor
Muhammad Rafehi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Pyrimidine nucleotides containing a (S)-methanocarba ring as P2Y6 receptor agonists
Kiran S. Toti et al.
MEDCHEMCOMM (2017)
Purinergic Signalling: Therapeutic Developments
Geoffrey Burnstock
FRONTIERS IN PHARMACOLOGY (2017)
Discovery of Potent Antiallodynic Agents for Neuropathic Pain Targeting P2X3 Receptors
Young-Hwan Jung et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A1 Receptor Agonist for the Chronic Treatment of Heart Diseases
Daniel Meibom et al.
CHEMMEDCHEM (2017)
Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies
Aliaa Abdelrahman et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Structure-Based Screening of Uncharted Chemical Space for Atypical Adenosine Receptor Agonists
David Rodriguez et al.
ACS CHEMICAL BIOLOGY (2016)
Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development
Sean Conroy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Computational Exploration of Molecular Scaffolds in Medicinal Chemistry
Ye Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Anthraquinones As Pharmacological Tools and Drugs
Enas M. Malik et al.
MEDICINAL RESEARCH REVIEWS (2016)
Medicinal chemistry of adenosine, P2Y and P2X receptors
Kenneth A. Jacobson et al.
NEUROPHARMACOLOGY (2016)
P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
Segundo J. Guzman et al.
NEURAL PLASTICITY (2016)
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists
Catia Lambertucci et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information
Silvia Paoletta et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2015)
Two disparate ligand-binding sites in the human P2Y1 receptor
Dandan Zhang et al.
NATURE (2015)
Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors
Mohamad Wessam Alnouri et al.
PURINERGIC SIGNALLING (2015)
Nucleotides Acting at P2Y Receptors: Connecting Structure and Function
Kenneth A. Jacobson et al.
MOLECULAR PHARMACOLOGY (2015)
Potential for Developing Purinergic Drugs for Gastrointestinal Diseases
Fernando Ochoa-Cortes et al.
INFLAMMATORY BOWEL DISEASES (2014)
Discovery of 4-Aryl-7-Hydroxyindoline-Based P2Y1 Antagonists as Novel Antiplatelet Agents
Wu Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Agonist-bound structure of the human P2Y12 receptor
Jin Zhang et al.
NATURE (2014)
Structure of the human P2Y12 receptor in complex with an antithrombotic drug
Kaihua Zhang et al.
NATURE (2014)
Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents
Gergely Horvath et al.
NEUROBIOLOGY OF DISEASE (2014)
BAY60-6583 Acts as a Partial Agonist at Adenosine A2B Receptors
Sonja Hinz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Ligand-Specific Binding and Activation of the Human Adenosine A2B Receptor
Dominik Thimm et al.
BIOCHEMISTRY (2013)
UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety
Tamar Ginsburg-Shmuel et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design
Miles Congreve et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Convergent Synthesis of the Potent P2Y Receptor Antagonist MG 50-3-1 Based on a Regioselective Ullmann Coupling Reaction
Younis Baqi et al.
MOLECULES (2012)
GPCR mediated regulation of synaptic transmission
Katherine M. Betke et al.
PROGRESS IN NEUROBIOLOGY (2012)
In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization
Anthony P. Ford
PURINERGIC SIGNALLING (2012)
A Novel Nonribose Agonist, LUF5834, Engages Residues That Are Distinct from Those of Adenosine-Like Ligands to Activate the Adenosine A2a Receptor
J. Robert Lane et al.
MOLECULAR PHARMACOLOGY (2012)
Recent developments in adenosine receptor ligands and their potential as novel drugs
Christa E. Mueller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
The Importance of Alkynyl Chain Presence for the Activity of Adenine Nucleosides/Nucleotides on Purinergic Receptors
D. Dal Ben et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Discovery of Potent Competitive Antagonists and Positive Modulators of the P2X2 Receptor
Younis Baqi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Molecular Determinants of Potent P2X2 Antagonism Identified by Functional Analysis, Mutagenesis, and Homology Docking
Christian Wolf et al.
MOLECULAR PHARMACOLOGY (2011)
Structure of an Agonist-Bound Human A2A Adenosine Receptor
Fei Xu et al.
SCIENCE (2011)
The birth and postnatal development of purinergic signalling
G. Burnstock et al.
ACTA PHYSIOLOGICA (2010)
A High-Throughput 1,536-Well Luminescence Assay for Glutathione S-Transferase Activity
Adam Yasgar et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2010)
NF546 [4,4 '-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha '-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y(11) Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells
Sabine Meis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions
Younis Baqi et al.
NATURE PROTOCOLS (2010)
Adenosine A(2A) Receptor Antagonists: New 8-Substituted 9-Ethyladenines as Tools for in vivo Rat Models of Parkinson's Disease
Rosaria Volpini et al.
CHEMMEDCHEM (2009)
High-Affinity, Non-Nucleotide-Derived Competitive Antagonists of Platelet P2Y12 Receptors
Younis Baqi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Key Determinants of Nucleotide-Activated G Protein-Coupled P2Y2 Receptor Function Revealed by Chemical and Pharmacological Experiments, Mutagenesis and Homology Modeling
Petra Hillmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity
Thomas Borrmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor
Kristina Hoffmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
ATP-gated P2X cation-channels
Michael F. Jarvis et al.
NEUROPHARMACOLOGY (2009)
Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y(2) receptor antagonists
Stefanie Weyler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
Veli-Pekka Jaakola et al.
SCIENCE (2008)
From ATP to AZD6140:: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis
Brian Springthorpe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-activity relationships of 2,N6,5′-substituted adenosine derivatives with potent activity at the A2B adenosine receptor
Hayamitsu Adachi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Rapid and efficient microwave-assisted copper(0)-catalyzed ullmann coupling reaction:: General access to anilinoanthraquinone derivatives
Younis Baqi et al.
ORGANIC LETTERS (2007)
Potent, selective, and orally active adenosine A2A receptor antagonists:: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
Bernard R. Neustadt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-activity relationships of novel P2-receptor antagonists structurally related to Reactive Blue 2
M Glänzel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor
LCW Chang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Agonist versus antagonist action of ATP at the P2Y4 receptor is determined by the second extracellular loop
CL Herold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors
ZG Gao et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Diisothiocyanate derivatives as potent, insurmountable antagonists of P2y6 nucleotide receptors
LK Mamedova et al.
BIOCHEMICAL PHARMACOLOGY (2004)
2-substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation:: Enhanced potency as P2Y1 receptor antagonists
HS Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Fluorescent and colored trinitrophenylated analogs of ATP and GTP
T Hiratsuka
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Robert Berne: His place in the history of purine research
RA Ollsson
DRUG DEVELOPMENT RESEARCH (2003)
Constitutional isomers of Reactive Blue 2 -: selective P2Y-receptor antagonists?
M Glänzel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Evaluation of reactive blue 2 derivatives as selective antagonists for P2Y receptors
J Brown et al.
VASCULAR PHARMACOLOGY (2002)
Evidence for the recognition of non-nucleotide antagonists within the transmembrane, domains of the human P2Y1 receptor
DP Guo et al.
DRUG DEVELOPMENT RESEARCH (2002)
Adenine nucleotide analogues locked in a northern methanocarba conformation:: Enhanced stability and potency as P2Y1 receptor agonists
RG Ravi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
1,8-disubstituted xanthine derivatives:: Synthesis of potent A2B-selective adenosine receptor antagonists
AM Hayallah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells
K Patel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor:: Structure-activity relationships and receptor docking
HS Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Actions of a series of PPADS analogs at P2X1 and P2X3 receptors
SG Brown et al.
DRUG DEVELOPMENT RESEARCH (2001)
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors
YC Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography
S Todde et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
A novel pharmacological approach to treating cardiac ischemia -: Binary conjugates of A1 and A3 adenosine receptor agonists
KA Jacobson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Platelet P2 receptors: from curiosity to clinical targets
NJ Cusack et al.
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM (2000)
In search of selective P2 receptor ligands:: interaction of dihydropyridine derivatives at recombinant rat P2X2 receptors
KA Jacobson et al.
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM (2000)
Diinosine pentaphosphate:: an antagonist which discriminates between recombinant P2X3 and P2X2/3 receptors and between two P2X receptors in rat sensory neurones
PM Dunn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors
YC Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
